Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
NCT00779454
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Cholangiocarcinoma
Interventions
DRUG:
Gemcitabine, Oxaliplatin, Capecitabine,
DRUG:
Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine
Sponsor
Vejle Hospital